Maintenance treatment with fluoropyrimidine plus bevacizumab versus fluoropyrimidine alone after induction chemotherapy for metastatic colorectal cancer: The BEVAMAINT - PRODIGE 71 - (FFCD 1710) phase III study

Maintenance treatments with fluoropyrimidine alone or combined with bevacizumab after induction chemotherapy are two standard options in first-line metastatic colorectal cancer (mCRC). However, no trial has compared these two maintenance regimens.

Source: Digestive and Liver Disease - July 30, 2020 Category: Gastroenterology Authors: Manfredi Sylvain, Turpin Anthony, Malka David, Barbier Emilie, Laurent-Puig Pierre, Zaanan Aziz, Dahan Laeticia, Li èvre Astrid, Phelip Jean-Marc, Michel Pierre, Hautefeuille Vincent, Legoux Jean-Louis, Lepage Côme, Tougeron David, Aparicio Thomas Tags: Progress Report Source Type: research